DOI: 10.1055/s-00030576

Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics


Hill S, Khullar V, Wyndaele JJ, Lheritier K ; Darifenacin Study Group.
Dose response with darifenacin, a novel once-daily M3 selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study.

Int Urogynecol J Pelvic Floor Dysfunct 2006;
17 (3) 239-247

Download Bibliographical Data

Search in: